References
Leishmaniosis in dogs and cats
Abstract
Leishmania spp, intracellular protozoan parasites, are the causative agents of a spectrum of clinical diseases in humans and animals, collectively called ‘leishmaniosis’. Leishmania are endemic in more than 98 countries, mainly in the Mediterranean region, Africa, Southern Asia, and Latin America, affecting more than 1 million people per year and causing significant public health risks. Canine leishmaniosis (CanL) is caused by Leishmania infantum; the only Leishmania spp. reported in both Old (Africa, Asia, Europe) and New (the Americas) Worlds and can cause fatal disease in humans and dogs. In cats five Leishmania spp. have been identified. These include Leishmania amazonensis, Leishmania braziliensis, Leishmania mexicana, and Leishmania venezuelensis in the New World, and L. infantum in both the New and Old Worlds.
The prevalence of CanL in endemic regions (Albania, Croatia, Cyprus, Greece, France, Italy, Malta, Portugal, and Spain) and its expansion towards new, non-endemic locations has increased in recent years, presumably because of the increased mobility of dogs, tourism (domestic and international) and climatic changes. Likewise, the past few years has witnessed the emergence of an increasing number of Leishmania infections in cats from endemic areas in Italy, France, Spain, and Portugal. Also, four cases have been diagnosed in Switzerland in cats that had travelled to or been imported from Spain. The prevalence of leishmaniosis is predicted to continue to grow, creating more opportunities for the establishment of new endemic Leishmania foci in central and northern Europe (Pennisi, 2015).
Register now to continue reading
Thank you for visiting The Veterinary Nurse and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.